Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | ung, Yoon Yang | - |
dc.contributor.author | Hyun, C.L | - |
dc.contributor.author | Jin, M.-S. | - |
dc.contributor.author | Park, I.A. | - |
dc.contributor.author | Chung, Y.R. | - |
dc.contributor.author | Shim, B. | - |
dc.contributor.author | Lee, K.H. | - |
dc.contributor.author | Ryu, H.S. | - |
dc.date.accessioned | 2022-07-15T07:08:44Z | - |
dc.date.available | 2022-07-15T07:08:44Z | - |
dc.date.created | 2021-05-14 | - |
dc.date.issued | 2016-09 | - |
dc.identifier.issn | 1738-6756 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/153939 | - |
dc.description.abstract | Purpose: There is no standard targeted therapy for the treatment of triple-negative breast cancer (TNBC). Therefore, its management heavily depends on adjuvant chemotherapy. Using core needle biopsy, this study evaluated the histological factors of TNBC predicting the response to chemotherapy. Methods: One hundred forty-three TNBC patients who received single-regimen neoadjuvant chemotherapy (NAC) with the combination of doxorubicin, cyclophosphamide, and docetaxel were enrolled. The core needle biopsy specimens acquired before NAC were used to analyze the clinicopathologic variables and overall performance of the predictive model for therapeutic response. Results: Independent predictors of pathologic complete response after NAC were found to be higher number of tumor infiltrating lymphocytes (p= 0.007), absence of clear cytoplasm (p= 0.008), low necrosis (p= 0.018), and high histologic grade (p= 0.039). In the receiver operating characteristics curve analysis, the area under curve for the combination of these four variables was 0.777. Conclusion: The present study demonstrated that a predictive model using the above four variables can predict therapeutic response to single-regimen NAC with the combination of doxorubicin, cyclophosphamide, and docetaxel in TNBC. Therefore, adding these morphologic variables to clinical and genomic signatures might enhance the ability to predict the therapeutic response to NAC in TNBC. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN BREAST CANCER SOC | - |
dc.title | Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | ung, Yoon Yang | - |
dc.identifier.doi | 10.4048/jbc.2016.19.3.261 | - |
dc.identifier.scopusid | 2-s2.0-84992027982 | - |
dc.identifier.wosid | 000384386800005 | - |
dc.identifier.bibliographicCitation | JOURNAL OF BREAST CANCER, v.19, no.3, pp.261 - 267 | - |
dc.relation.isPartOf | JOURNAL OF BREAST CANCER | - |
dc.citation.title | JOURNAL OF BREAST CANCER | - |
dc.citation.volume | 19 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 261 | - |
dc.citation.endPage | 267 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.identifier.kciid | ART002148684 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | LYMPH-NODE METASTASIS | - |
dc.subject.keywordPlus | PATHOLOGICAL COMPLETE RESPONSE | - |
dc.subject.keywordPlus | CORE NEEDLE-BIOPSY | - |
dc.subject.keywordPlus | PREOPERATIVE TREATMENT | - |
dc.subject.keywordPlus | RETRACTION ARTIFACT | - |
dc.subject.keywordPlus | FEATURES | - |
dc.subject.keywordPlus | DOXORUBICIN | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | CELL | - |
dc.subject.keywordPlus | SKI-67 | - |
dc.subject.keywordAuthor | Core needle biopsy | - |
dc.subject.keywordAuthor | Neoadjuvant therapy | - |
dc.subject.keywordAuthor | Treatment outcome | - |
dc.subject.keywordAuthor | Triple-negative breast neoplasms | - |
dc.identifier.url | https://ejbc.kr/DOIx.php?id=10.4048/jbc.2016.19.3.261 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.